Penn Spinout Heirloom Technologies and Microsoft Sign One of the Largest Permanent CO2 Removal Deals To-Date 

Microsoft signed a long term contract to purchase up to 315,000 metric tons of CO2 removal over a multi-year period from Penn spinout Heirloom Carbon Technologies.

Penn spinout BlueWhale Bio comes out of stealth mode

In September 2023, Penn spinout BlueWhale Bio surfaced with a mission to overhaul cell therapy production.

Exyn Technologies Closes on Series B Funding

Exyn has a mission to deliver world-class autonomous robots to data-hungry industries that include mining, logistics and construction. 

Katalin Karikó and Drew Weissman Named Co-Recipients of the 2023 Nobel Prize for Medicine 

Penn’s Katalin Karikó, PhD, and Drew Weissman, MD, PhD, have been named winners of the 2023 Nobel Prize in Physiology or Medicine.

Penn grads develop The Community Grocer to provide hot food for those using SNAP benefits

Penn graduates Alex Imbot ‘20 and Eli Moraru ‘21 were featured in the Inquirer for their non-profit corner store idea, The Community Grocer, which improves food access for those using SNAP benefits.

Mitchell Named “Young Innovator of Cellular and Molecular Bioengineering”

Mike Mitchell, PhD, J. Peter and Geri Skirkanich Assistant Professor of Innovation in Bioengineering (BE), was named a "Young Innovator of Cellular and Molecular Bioengineering."

New research from the Mitchell Lab offers a safer path for CAR T cell immunotherapy

The new method involves attaching a sugar molecule onto the surface of CAR T cells using metabolic labeling, a modification that enables the CAR T cells to attack cancer cells without any hindrance.

Carl June to receive the 2024 Breakthrough Prize in Life Sciences

June was awarded for the development of chimeric antigen receptor (CAR) T cell immunotherapy.

Penn is the one of the world’s best universities for VC-seeking entrepreneurs, per PitchBook data

PitchBook released its 2023 list of the best universities for founders, and Penn ranked fourth among undergraduate schools with 1,083 founders, 993 companies and $34 billion raised.

Bruce Levine Speaks on the Progress of CAR T at the 2023 CAR-TCR Summit

In this recorded event, which took place on the six-year anniversary of the first approved CAR-T  Levine, discusses emerging technology trends that might improve CAR-T therapies.

Filter

Success Stories

Highlights of the PCI news focused on Penn commercialization accomplishments

All Success Stories
Skip to content